Bong yKoh

Bong yKoh has an estimated net worth of $442 Million. This is based on reported shares across multiple companies, which include Oruka Therapeutics, Inc., Avalanche Biotechnologies, Inc., CONSTELLATION PHARMACEUTICALS INC, Shockwave Medical, Inc., KalVista Pharmaceuticals, Inc., Altimmune, Inc., Unum Therapeutics Inc., Bellerophon Therapeutics, Inc., Tricida, Inc., Vistagen Therapeutics, Inc., and AveXis, Inc..

2022 was Bong yKoh's most active year for acquiring shares with 46 total transactions. Bong yKoh's most active month to acquire stocks was the month of December. 2018 was Bong yKoh's most active year for disposing of shares, totalling 7 transactions. Bong yKoh's most active month to dispose stocks was the month of February. 2019 saw Bong yKoh paying a total of $13,899,999.90 for 4,786,899 shares, this is the most they've acquired in one year. In 2019 Bong yKoh cashed out on 1,593,847 shares for a total of $14,899,957.25, their largest year based on trade value.